Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SHSE:600436's Days Payable is ranked worse than 85.53% of 926
companies
in the Drug Manufacturers industry
Industry Median: 90.455
vs SHSE:600436: 35.89
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhangzhou Pientzehuang Pharmaceutical Co Days Payable Chart
Zhangzhou Pientzehuang Pharmaceutical Co Annual Data
SHSE:600436 vs LLY, JNJ, ABBV: Days Payable Comparison
For the Drug Manufacturers - General subindustry, Zhangzhou Pientzehuang Pharmaceutical Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zhangzhou Pientzehuang Pharmaceutical Co Days Payable vs Drug Manufacturers Industry
Zhangzhou Pientzehuang Pharmaceutical Co Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhangzhou Pientzehuang Pharmaceutical Co (SHSE:600436) has a Days Payable of 32.12 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Zhangzhou Pientzehuang Pharmaceutical Co and its competitors. This is near median its historical median of 32.93. Over the past decade, Zhangzhou Pientzehuang Pharmaceutical Co's Days Payable has ranged from 25.64 to 48.71. According to the industry distribution chart, Zhangzhou Pientzehuang Pharmaceutical Co ranks #792 out of 926 companies in the Drug Manufacturers industry, placing it in the top 85.5%.
Is Zhangzhou Pientzehuang Pharmaceutical Co's Days Payable too high?
Zhangzhou Pientzehuang Pharmaceutical Co's current Days Payable of 32.12 is near median its 10-year median of 32.93. Over the past 10 years, this metric has ranged from a low of 25.64 to a high of 48.71. The Drug Manufacturers industry median Days Payable is 90.46. Zhangzhou Pientzehuang Pharmaceutical Co's value of 32.12 is 64.5% below this industry median. Based on the distribution chart, Zhangzhou Pientzehuang Pharmaceutical Co ranks #792 out of 926 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Zhangzhou Pientzehuang Pharmaceutical Co has a GF Score™ of 86/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zhangzhou Pientzehuang Pharmaceutical Co's Days Payable compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Zhangzhou Pientzehuang Pharmaceutical Co ranks #792 out of 926 companies for Days Payable. This places Zhangzhou Pientzehuang Pharmaceutical Co in the lower half of its industry. The industry median Days Payable is 90.46. Zhangzhou Pientzehuang Pharmaceutical Co's value of 32.12 is 64.5% below this benchmark. Historically, Zhangzhou Pientzehuang Pharmaceutical Co's own Days Payable has ranged from 25.64 to 48.71 over the past decade. While the company's 10-year median is 32.93 vs. the industry median of 90.46, Zhangzhou Pientzehuang Pharmaceutical Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.46, based on 926 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zhangzhou Pientzehuang Pharmaceutical Co's current Days Payable of 32.12 is 64.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Zhangzhou Pientzehuang Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zhangzhou Pientzehuang Pharmaceutical Co's current Days Payable is 32.12, which is near median its own 10-year median of 32.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhangzhou Pientzehuang Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Zhangzhou Pientzehuang Pharmaceutical Co (SHSE:600436) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥172.67, compared to a current price of ¥146.63 — trading 15.1% below its estimated fair value. The current Days Payable is 32.12, which is near median its 10-year median of 32.93 and 64.5% below the Drug Manufacturers industry median of 90.46. Zhangzhou Pientzehuang Pharmaceutical Co's overall GF Score™ is 86/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Zhangzhou Pientzehuang Pharmaceutical Co (SHSE:600436), the current Days Payable is 32.12 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zhangzhou Pientzehuang Pharmaceutical Co (SHSE:600436) Overvalued in 2026?
Based on GuruFocus' analysis, Zhangzhou Pientzehuang Pharmaceutical Co stock appears to be undervalued.
The current stock price of ¥146.63 is trading 15.1% below its estimated GF Value™ of ¥172.67.
GuruFocus considers Zhangzhou Pientzehuang Pharmaceutical Co to be Modestly Undervalued.
Key valuation signals for SHSE:600436:
Days Payable: 32.12 (near median its 10-year median of 32.93)
GF Value™: ¥172.67 vs. price of ¥146.63 (15.1% below fair value)
Industry Position: 64.5% below the Drug Manufacturers median (#792 of 926)
No single metric tells the full story. See the SHSE:600436 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zhangzhou Pientzehuang Pharmaceutical Co Business Description
Zhangzhou Pientzehuang Pharmaceutical Co Ltd produces and sells Chinese medicines. The company's product categories include tablets, hard capsules, granules, pills (water pills, honey pills), syrups, tinctures (including external use), ointments, lozenges, decoctions, Chinese herbal medicine slices (including direct oral slices) (clean preparation); production of candy products (candy), health food products; and production of beverages (solid beverages).
86GF Score
Get the complete analysis for SHSE:600436
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600436 has been successfully added to your 
